Under the leadership of Co-Founder and CEO Tim Blair, ICHOR Vascular Inc. is advancing a new approach to treating peripheral vascular occlusions by converting one...
Category: Press Release
Ichor Vascular Commences Limited Market Release of 7-F Peripheral Reperfusion System
February 27, 2025—Ichor Vascular, Inc. announced the limited market release of its 7-F peripheral reperfusion system.In July 2024, the company announced FDA 510(k) clearance for the 7-F...
Ichor Vascular’s 14-F Peripheral Reperfusion System Cleared by FDA
July 18, 2024—Ichor Vascular Inc. announced it has received FDA 510(k) clearance for the company’s 7-F peripheral reperfusion system, which is indicated for the nonsurgical...
